Prediction Model For Extensive Ductal Carcinoma In Situ Around Early-Stage Invasive Breast Cancer

ObjectivesDuctal carcinoma in situ (DCIS) is a risk factor for incomplete resection of breast cancer. Especially, extensive DCIS (E-DCIS) or extensive intraductal component often results in positive resection margins. Detecting DCIS around breast cancer before treatment may therefore alter surgery. The purpose of this study was to develop a prediction model for E-DCIS around early-stage invasive breast cancer, using clinicohistopathological and dynamic contrast-enhanced magnetic resonance imaging (MRI) features. Materials and MethodsDynamic contrast-enhanced MRI and local excision were performed in 322 patients with 326 ductal carcinomas. Tumors were segmented from dynamic contrast-enhanced MRI, followed by 3-dimensional extension of the margins with 10 mm. Amount of fibroglandular tissue (FGT) and enhancement features in these extended margins were automatically extracted from the MRI scans. Clinicohistopathological features were also obtained. Principal component analysis and multivariable logistic regression were used to develop a prediction model for E-DCIS. Discrimination and calibration were assessed, and bootstrapping was applied for internal validation. ResultsExtensive DCIS occurred in 48 (14.7%) of 326 tumors. Incomplete resection occurred in 56.3% of these E-DCIS–positive versus 9.0% of E-DCIS–negative tumors (P < 0.001). Five components with eigenvalue exceeding 1 were identified; 2 were significantly associated with E-DCIS. The first, positively associated, component expressed early and overall enhancement in the 10-mm tissue margin surrounding the MRI-visible tumor. The second, positively associated, component expressed human epidermal growth factor receptor 2 and amount of FGT around the MRI-visible tumor. The area under the curve value was 0.79 (0.76 after bootstrapping). ConclusionsHuman epidermal growth factor receptor 2 status, early and overall enhancement in the 10-mm margin around the MRI-visible tumor, and amount of FGT in the 10 mm around the MRI-visible tumor were associated with E-DCIS.

[1]  W. McGuire,et al.  Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer. , 1992, Human pathology.

[2]  Sehwan Han,et al.  HER2 status in pure ductal carcinoma in situ and in the intraductal and invasive components of invasive ductal carcinoma determined by fluorescence in situ hybridization and immunohistochemistry , 2006, Histopathology.

[3]  E. Rutgers,et al.  Avoiding preoperative breast MRI when conventional imaging is sufficient to stage patients eligible for breast conserving therapy. , 2014, European journal of radiology.

[4]  Eunyoung Kang,et al.  Factors Associated with Re-excision after Breast-Conserving Surgery for Early-Stage Breast Cancer , 2012, Journal of breast cancer.

[5]  Valentina Taviani,et al.  Assessment of tumor morphology on diffusion‐weighted (DWI) breast MRI: Diagnostic value of reduced field of view DWI , 2015, Journal of magnetic resonance imaging : JMRI.

[6]  Ralf-Dieter Hilgers,et al.  Abbreviated breast magnetic resonance imaging (MRI): first postcontrast subtracted images and maximum-intensity projection-a novel approach to breast cancer screening with MRI. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  N. Houssami,et al.  Meta‐analysis of the effect of preoperative breast MRI on the surgical management of ductal carcinoma in situ , 2015, The British journal of surgery.

[8]  Jeffrey L Myers,et al.  Intraoperative frozen section analysis of margins in breast conserving surgery significantly decreases reoperative rates: one-year experience at an ambulatory surgical center. , 2012, American journal of clinical pathology.

[9]  A. Magener,et al.  Extensive and predominant in situ component in breast carcinoma: their influence on treatment results after breast-conserving therapy. , 1998, European Journal of Cancer.

[10]  Nathan D. Shemonski,et al.  Real-time Imaging of the Resection Bed Using a Handheld Probe to Reduce Incidence of Microscopic Positive Margins in Cancer Surgery. , 2015, Cancer research.

[11]  R Holland,et al.  Breast carcinomas of limited extent , 2001, Cancer.

[12]  Seema A Khan,et al.  Society of Surgical Oncology–American Society for Radiation Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Stages I and II Invasive Breast Cancer , 2014, Annals of Surgical Oncology.

[13]  Gary S Collins,et al.  Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration , 2015, Annals of Internal Medicine.

[14]  I. Ellis,et al.  Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. , 2002, Histopathology.

[15]  W. Moon,et al.  Background parenchymal signal enhancement ratio at preoperative MR imaging: association with subsequent local recurrence in patients with ductal carcinoma in situ after breast conservation surgery. , 2013, Radiology.

[16]  Role of Preoperative Breast MRI in Ductal Carcinoma In Situ for Prediction of the Presence and Assessment of the Extent of Occult Invasive Component , 2014, The breast journal.

[17]  Ivan Dmitriev,et al.  Association between Parenchymal Enhancement of the Contralateral Breast in Dynamic Contrast-enhanced MR Imaging and Outcome of Patients with Unilateral Invasive Breast Cancer. , 2015, Radiology.

[18]  M. Morrow,et al.  Effect of margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  C. Klifa,et al.  Quantification of breast tissue index from MR data using fuzzy clustering , 2004, The 26th Annual International Conference of the IEEE Engineering in Medicine and Biology Society.

[20]  Zhao-xiang Gu,et al.  Accuracy of estrogen receptor, progesterone receptor, and HER2 status between core needle and open excision biopsy in breast cancer: a meta-analysis , 2012, Breast Cancer Research and Treatment.

[21]  S. Partridge,et al.  Diffusion weighted magnetic resonance imaging of the breast: protocol optimization, interpretation, and clinical applications. , 2013, Magnetic resonance imaging clinics of North America.

[22]  Craig K. Enders,et al.  A Primer on Maximum Likelihood Algorithms Available for Use With Missing Data , 2001 .

[23]  C. Catalano,et al.  Effect of Preoperative Breast Magnetic Resonance Imaging on Surgical Decision Making and Cancer Recurrence Rates , 2012, Investigative radiology.

[24]  L. Holmberg,et al.  Standardization of the surgical technique in breast‐conserving treatment of mammary cancer , 1988, The British journal of surgery.

[25]  N. Robert,et al.  Factors influencing cosmetic outcome and complication risk after conservative surgery and radiotherapy for early-stage breast carcinoma. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  J. Hendriks,et al.  Extent, distribution, and mammographic/ histological correlations of breast ductal carcinoma in situ , 1990, The Lancet.

[27]  K. Chew,et al.  High mammographic breast density is independent predictor of local but not distant recurrence after lumpectomy and radiotherapy for invasive breast cancer. , 2009, International journal of radiation oncology, biology, physics.

[28]  T. Helbich,et al.  Quantitative Apparent Diffusion Coefficient as a Noninvasive Imaging Biomarker for the Differentiation of Invasive Breast Cancer and Ductal Carcinoma In Situ , 2015, Investigative radiology.

[29]  G. Santamaría,et al.  Preoperative MRI of pure intraductal breast carcinoma--a valuable adjunct to mammography in assessing cancer extent. , 2008, Breast.

[30]  R. Kane,et al.  Tumor characteristics as predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis , 2011, Breast Cancer Research and Treatment.

[31]  T. Ishibashi,et al.  Correlation of three-dimensional magnetic resonance imaging with precise histopathological map concerning carcinoma extension in the breast , 2000, Breast Cancer Research and Treatment.

[32]  M. A. van den Bosch,et al.  Prediction of positive resection margins in patients with non-palpable breast cancer. , 2015, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[33]  N M Hylton,et al.  Vascularity assessment of breast lesions with gadolinium-enhanced MR imaging. , 1999, Magnetic resonance imaging clinics of North America.

[34]  H. Nisenbaum,et al.  The significance of HER‐2/neu receptor positivity and immunophenotype in ductal carcinoma in situ with early invasive disease , 2011, Journal of surgical oncology.

[35]  S. Schnitt,et al.  Evolution of breast-conserving therapy for localized breast cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[36]  P. Macaskill,et al.  The Association of Surgical Margins and Local Recurrence in Women with Early-Stage Invasive Breast Cancer Treated with Breast-Conserving Therapy: A Meta-Analysis , 2014, Annals of Surgical Oncology.

[37]  J. Habbema,et al.  Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. , 2001, Journal of clinical epidemiology.

[38]  M L Giger,et al.  Computerized analysis of breast lesions in three dimensions using dynamic magnetic-resonance imaging. , 1998, Medical physics.

[39]  G. Porter,et al.  Ductal carcinoma in situ in core biopsies containing invasive breast cancer: correlation with extensive intraductal component and lumpectomy margins , 2005, Journal of surgical oncology.

[40]  C. Dziuban,et al.  When is a correlation matrix appropriate for factor analysis? Some decision rules. , 1974 .

[41]  J. Peterse,et al.  The impact of preoperative MRI on breast-conserving surgery of invasive cancer: a comparative cohort study , 2009, Breast Cancer Research and Treatment.

[42]  Elizabeth A Morris,et al.  Determination of the Presence and Extent of Pure Ductal Carcinoma in Situ by Mammography and Magnetic Resonance Imaging , 2005, The breast journal.

[43]  Karel G M Moons,et al.  Meta-analysis of MR imaging in the diagnosis of breast lesions. , 2008, Radiology.

[44]  Patrick Tas,et al.  Intra-operative touch preparation cytology following lumpectomy for breast cancer: a series of 400 procedures. , 2009, Breast.

[45]  Heng Tao Shen,et al.  Principal Component Analysis , 2009, Encyclopedia of Biometrics.

[46]  Elizabeth S. McDonald,et al.  Diffusion weighted MRI of the breast: Protocol optimization, guidelines for interpretation, and potential clinical applications , 2013 .

[47]  J. Lynch,et al.  Trends in Area-Socioeconomic and Race-Ethnic Disparities in Breast Cancer Incidence, Stage at Diagnosis, Screening, Mortality, and Survival among Women Ages 50 Years and Over (1987-2005) , 2009, Cancer Epidemiology Biomarkers & Prevention.

[48]  Tanja Alderliesten,et al.  Validation of Semiautomatic Measurement of the Extent of Breast Tumors Using Contrast-Enhanced Magnetic Resonance Imaging , 2007, Investigative radiology.

[49]  J. Biggart,et al.  c-erbB-2 overexpression and histological type of in situ and invasive breast carcinoma. , 1992, Journal of clinical pathology.